The Superhuman Cell
Superhuman cell biology is changing the course of advanced medicines and complex diseases that have hampered humanity. Our systems and customers are leveraging the super human cells in all of us to advance human health. Our systems, which uniquely reveal these superhuman cells through single-cell & proteomic innovations, are enabling customers to advance the future of medicines against complex disease.
Superhuman Cell Biology Has Been Published in 100 Publications
Introducing the Superhuman Cell Library

The Superhuman Cell Library provides the functional proteomic drivers of each cell, using IsoPlexis' unique functional cell phenotyping, which has been shown in the literature to underlie various long-term responses and disease states in major areas of human health.

Introducing Duomic

For the first time, find the underlying genetic code of the proteomically driven superhuman cells that drive response to complex disease. This information can be used to recode and replicate superhero cells to drive the future of high resolution discovery biology.

Our Systems Detect Superhuman Cells and
Their Proteomic Environment

Capture the “super” single cells with the highest multiplexed proteomic signatures


Leverage wide bodies of peer reviewed data demonstrating the predictive power of super cells


Access data real time with advanced analytic visualizations

Access Superhuman Cells and their Benefits Today

Utilize the single cell functional protomics hub to
accelerate advanced medicines for human health

Our Solutions

The Products Driving Our Superpowered Biology

Reveal the Superhero and
Villain Cells in All of Us
Functional Immune Landscaping

The Single-Cell Secretome: Cytokines, Chemokines, Growth Factors

Website_Homepage Icons__-electical circuits inside
Unlock the Electric
Wiring Behind Supercells
Intracellular Signaling Omics

The Single-Cell Phosphoproteome: Kinases, Translation & Transcription Factors

Unlock the Genetic Code
Behind Superhero Cells

Single-Cell Functional Proteomics and Transcriptomics

Website_Homepage Icons__New
Reveal the Bulk
Proteomic Environment
High-plex Walk-Away Immunoassays

Easily Accessible, Yet Comprehensive Bulk Proteome


Superhuman Cell Biology Built on a Strong Foundation

Superhuman Biology

Proteomics, Reimagined to uniquely detect our most powerful cells.

Explore Our Biology

Instrument Virtual Demo
Virtual Demo

The entire ELISA proteomics workflow, sample to answer.

Take the Virtual Tour

Data Visualization Tour

IsoSpeak Software: Same day visualizations and insights.

Tour the Visualizations

Areas of Interest

See how we can shift the paradigms in your programs


Enabling a New Era of Precision Medicine

Latest Customer Stories View Blog

Using Functional Proteomics to Better Understand Mechanisms of COVID-19
Blog Post_Revealing the Orchestrators of Immune Response_jt (1)
Revealing The Orchestrators of Immune Response with IsoPlexis’ Single-Cell Secretome Solution
Blog Post_Molecular Cancer Therapeutics Using Single-Cell Secretome_jt (2)
Published in Molecular Cancer Therapeutics: Using Single-Cell Secretome to Understand How Immune Cells Respond to Cancer Therapy

Featured Content

Trusted Worldwide

We innovated the only way to measure the true function of each cell and identify the rare subsets of superpowered cells driving response.

As a cancer research center with a key focus on CAR-T and other cell therapies, we feel that IsoPlexis will enable us to better characterize response and potentially predict whether cancer patients will respond to CAR-T therapy before treatment.
Christine Brown, PHD

City of Hope

The future is very powerful here. One can study autoimmunity and cancer biology, one can take out from the blood single cells, one can analyze those cells and get an overall picture from integrating that analysis.
Arnold Levine, PHD

Professor Emeritus, Simons Center for Systems Biology, Institute for Advanced Study

Quality assays are mainly descriptive with some objective parameters like cytokine production, cytotoxicity, and proliferation. Only recently, with PSI… can we start to differentiate products.
Marco L Davila, MD, PHD

Moffitt Cancer Center

We see potential in utilizing IsoPlexis’ single-cell system to help provide deeper resolution into the functional impacts of our therapeutics… This collaboration will enable us to apply the sensitivity of this solution to further our understanding of patient-specific responses to our immune therapies.
Jon Zalevsky, PHD

Chief Scientific Officer, Nektar Therapeutics

Through this research, we were able to highlight the important role a functionally versatile subpopulation of CAR-T cells may play in the fight against cancer. This could lead to new methods to optimize T-cell products.
Adrian Bot, MD, PHD

Vice President, Translation Sciences, Kite

Current assays that rely on a single-plex ELISA or even multiparametric flow cytometry don’t give you the level of resolution that the IsoPlexis platform can provide.
John Rossi

Director of Translational Sciences at Kite

Spark the Next Breakthrough